Chemoinformaics analysis of 1,8-Dihydroxy-3,5,7-trimethoxy-2-methylanthraquinone
Molecular Weight | 344.319 | nRot | 3 |
Heavy Atom Molecular Weight | 328.191 | nRig | 18 |
Exact Molecular Weight | 344.09 | nRing | 3 |
Solubility: LogS | -4.845 | nHRing | 0 |
Solubility: LogP | 3.669 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
nHA | 7 | APOL | 46.3427 |
nHD | 2 | BPOL | 22.9953 |
QED | 0.751 |
Synth | 2.475 |
Natural Product Likeliness | 1.423 |
NR-PPAR-gamma | 0.453 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.522 |
Pgp-sub | 0.01 |
HIA | 0.384 |
CACO-2 | -5.208 |
MDCK | 0.0000158 |
BBB | 0.015 |
PPB | 0.924486 |
VDSS | 0.464 |
FU | 0.0457313 |
CYP1A2-inh | 0.454 |
CYP1A2-sub | 0.97 |
CYP2c19-inh | 0.038 |
CYP2c19-sub | 0.472 |
CYP2c9-inh | 0.45 |
CYP2c9-sub | 0.59 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.36 |
CYP3a4-inh | 0.346 |
CYP3a4-sub | 0.413 |
CL | 11.919 |
T12 | 0.226 |
hERG | 0.006 |
Ames | 0.721 |
ROA | 0.175 |
SkinSen | 0.183 |
Carcinogencity | 0.336 |
EI | 0.911 |
Respiratory | 0.11 |
NR-Aromatase | 0.694 |
Antiviral | Yes |
Prediction | 0.828473 |